Literature DB >> 4209775

Sensitivity of an early step in the sporulation of Bacillus subtilis to selective inhibition by ethidium bromide.

M Rogolsky, H T Nakamura.   

Abstract

When a final concentration of 0.4 mug of ethidium bromide (EB) per ml, which is subinhibitory to vegetative growth, is added to sporulating cells of Bacillus subtilis Marburg during either stage 0 or the early part of stage 1, morphogenesis is blocked. If the given concentration of EB is added after the early part of stage 1, sporogenesis is unaffected. The synthesis of the serine protease and antibiotic, which are believed to be associated with sporulation events during the early part of stage 0, are not inhibited by EB. Enhanced binding of [(14)C]benzylpenicillin to sporulating cells during septation (stage 2) is a measure of the presence of terminal enzymes for germ cell wall peptidoglycan synthesis. EB does not interfere with the binding of penicillin to sporulating cells, but penicillin remains more permanently bound to EB-treated postlogarithmic cells than to untreated sporulating cells. The absence of an interval of increased penicillin binding activity during stage 2 by sporulating cells treated with EB indicates that EB blocks sporulation prior to the completion of the germ cell wall.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4209775      PMCID: PMC245572          DOI: 10.1128/jb.119.1.57-61.1974

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  16 in total

1.  COMPLEX FORMATION WITH DNA AND INHIBITION OF ESCHERICHIA COLI RNA POLYMERASE BY ETHIDIUM BROMIDE.

Authors:  M J WARING
Journal:  Biochim Biophys Acta       Date:  1964-06-22

2.  TRANSFORMATION OF BIOCHEMICALLY DEFICIENT STRAINS OF BACILLUS SUBTILIS BY DEOXYRIBONUCLEATE.

Authors:  J Spizizen
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

3.  Letter: Effect of ethidium bromide on transcription of linear and circular DNA templates.

Authors:  J P Richardson; S R Parker
Journal:  J Mol Biol       Date:  1973-08-25       Impact factor: 5.469

4.  Mechanism of ethidium bromide inhibition of RNA polymerase.

Authors:  J P Richardson
Journal:  J Mol Biol       Date:  1973-08-25       Impact factor: 5.469

5.  Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.

Authors:  M Rogolsky; R Warren; B B Wiley; H T Nakamura; L A Glasgow
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

6.  Catabolic repression of bacterial sporulation.

Authors:  P Schaeffer; J Millet; J P Aubert
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

7.  Appearance of a ribonucleic acid polymerase-binding protein in asporogenous mutants of Bacillus subtilis.

Authors:  A L Greenleaf; R Losick
Journal:  J Bacteriol       Date:  1973-10       Impact factor: 3.490

8.  Characterization of proteinases excreted by Bacillus subtilis Marburg strain during sporulation.

Authors:  J Millet
Journal:  J Appl Bacteriol       Date:  1970-03

9.  Binding of radioactive benzylpenicillin to sporulating Bacillus cultures: chemistry and fluctuations in specific binding capacity.

Authors:  P J Lawrence; M Rogolsky; V T Hanh
Journal:  J Bacteriol       Date:  1971-11       Impact factor: 3.490

10.  Protease activities during the course of sporulation on Bacillus subtilis.

Authors:  L Prestidge; V Gage; J Spizizen
Journal:  J Bacteriol       Date:  1971-09       Impact factor: 3.490

View more
  3 in total

Review 1.  Genetic aspects of bacterial endospore formation.

Authors:  P J Piggot; J G Coote
Journal:  Bacteriol Rev       Date:  1976-12

2.  Selective inhibition of Bacillus subtilis sporulation by acridine orange and promethazine.

Authors:  W F Burke; J Spizizen
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

3.  Benzeneboronic acid selectively inhibits sporulation of Bacillis subtilis.

Authors:  K Davis-Mancini; I P Lopez; J H Hageman
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.